¥777.00 ($4.92)

-14.00 (-1.77%)

Weekly Expected Move ±2.5%

¥738 ¥758 ¥777 ¥796 ¥816

JPX · Healthcare · Medical - Distribution · Tech Score Neutral · Power 51 · ¥17.3B mcap · 12M float · 0.287% daily turnover

Revenue

$288.7B +11.1% ▲

5Y CAGR: +6.5%

Gross Profit

$33.3B +7.1% ▲

5Y CAGR: +8.4%

Operating Income

$1.9B +41.3% ▲

5Y CAGR: +11.3%

Net Income

$1.4B +22.3% ▲

5Y CAGR: +7.7%

EPS (Diluted)

$61.85 +21.3% ▲

5Y CAGR: +7.2%

EBITDA

$4.8B +23.4% ▲

5Y CAGR: +17.7%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$246.8B	$221.7B	$239.1B	$259.8B	$288.7B
YoY Growth	+17.3%	-10.2%	+7.8%	+8.7%	+11.1%
Cost of Revenue	$221.6B	$194.3B	$209.7B	$228.7B	$255.4B
Gross Profit	$25.2B	$27.4B	$29.3B	$31.1B	$33.3B
Gross Margin	10.2%	12.4%	12.3%	12.0%	11.5%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$22.1B	$24.5B	$26.3B	$28.7B	$31.4B
Operating Expenses	$22.5B	$25.2B	$27.4B	$29.8B	$31.4B
Operating Income	$2.7B	$2.3B	$1.9B	$1.3B	$1.9B
Operating Margin	1.1%	1.0%	0.8%	0.5%	0.6%
Interest Expense	$54M	$69M	$85M	$99M	$174M
Income Before Tax	$3.2B	$2.6B	$2.5B	$1.9B	$2.4B
Tax Expense	$1.1B	$699M	$1.0B	$822M	$1.0B
Net Income	$2.1B	$1.9B	$1.5B	$1.1B	$1.4B
Net Margin	0.8%	0.8%	0.6%	0.4%	0.5%
EPS (Diluted)	$94.15	$85.15	$68.10	$51.00	$61.85
EBITDA	$4.1B	$3.8B	$4.3B	$3.9B	$4.8B
Shares Outstanding	22M	22M	22M	22M	22M

Line Item	FY2023 Q2	FY2023 Q3	FY2023 Q4	FY2024 Q1	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1
Revenue	$66.6B	$66.4B	$66.7B	$69.2B	$73.5B	$76.8B	$69.2B	$72.2B
Cost of Revenue	$58.7B	$58.5B	$58.9B	$61.0B	$64.9B	$67.8B	$61.2B	$63.9B
Gross Profit	$7.9B	$7.9B	$7.7B	$8.2B	$8.7B	$9.0B	$8.0B	$8.2B
Gross Margin	11.8%	11.9%	11.6%	11.8%	11.8%	11.7%	11.5%	11.4%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$7.0B	$7.0B	$7.8B	$7.8B	$7.8B	$7.7B	$8.1B	$8.1B
Operating Expenses	$7.3B	$7.0B	$8.1B	$8.0B	$8.1B	$7.7B	$8.1B	$8.1B
Operating Income	$583M	$968M	-$326M	$154M	$597M	$1.3B	-$151M	$150M
Operating Margin	0.9%	1.5%	-0.5%	0.2%	0.8%	1.7%	-0.2%	0.2%
Interest Expense	$25M	$24M	$29M	$36M	$39M	$50M	$48M	$50M
Income Before Tax	$699M	$1.1B	-$22M	$242M	$740M	$1.4B	-$33M	$266M
Tax Expense	$287M	$433M	-$851K	$168M	$408M	$478M	-$38M	$158M
Net Income	$412M	$641M	-$21M	$74M	$332M	$964M	$5M	$109M
Net Margin	0.6%	1.0%	-0.0%	0.1%	0.5%	1.3%	0.0%	0.2%
EPS (Diluted)	$18.70	$29.15	$-0.96	$3.33	$14.93	$43.35	$0.21	$4.88
EBITDA	$1.1B	$1.6B	$511M	$761M	$1.1B	$2.1B	$761M	$844M
Shares Outstanding	22M	22M	22M	22M	22M	22M	22M	22M

3154.T JPX